CXCR4 and pulmonary arterial hypertension: We studied the effects of silibinin [36,37,38], an inhibitor of chemokine receptor, CXC motif chemokine receptor type 4 (CXCR4), and found that CXCR4 expression was higher in PAH rats [37].